Eradivir
PrivateLast Round
Private Placement
Oct 7, 2025
Total Funding Raised
$11.1M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Eradivir operates in Healthcare & Life Sciences and is based in West Lafayette, Indiana. Its latest recorded funding round was a Private Placement round in October 2025.
Eradivir is a biotechnology company that develops immunotherapies to treat viral infections and other diseases using a proprietary small-molecule targeting platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eradivir Comparables
Compare Eradivir with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Via Nova Therapeutics | 84% | |
| Cocrystal Pharma Inc | 79% | |
| Astremiha Therapeutics | 77% |
For institutional investors. Book with your work email.
Eradivir Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Oct 7, 2025 | ||||
| Series A | Sep 23, 2024 | ||||
| Grant | Sep 18, 2023 | ||||
| Grant | Feb 15, 2021 | ||||
| Seed | Apr 15, 2020 |
For institutional investors. Book with your work email.
Eradivir Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Administration for Strategic Preparedness and Response | Grant |
| Research Bridge Partners | Seed |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 75% MoM.
- Jul 25, 2026
Monthly visitors increased 54% MoM.
For institutional investors. Book with your work email.
Eradivir Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Eradivir's valuation, stock price, and market status.
Is Eradivir a public or private company?
Eradivir is a private company.
What is the current stock price of Eradivir?
Eradivir is a private company, so its shares have no public market price. Caplight tracks Eradivir's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Eradivir worth (valuation)?
Valuation information for Eradivir is not publicly available.
Can I buy Eradivir stock?
Eradivir shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Eradivir's last funding round?
Eradivir's most recent funding round was Private Placement on October 7, 2025.
Who are the main investors in Eradivir?
Key investors in Eradivir include Research Bridge Partners.
Will Eradivir IPO soon?
No public IPO plans have been announced for Eradivir.
How can I track Eradivir secondary market activity?
Caplight tracks bids, offers, and trades in Eradivir's shares on secondary markets.